Al-Ghanem, G. et al. Bronchopulmonary dysplasia and pulmonary hypertension: A meta-analysis. J. Perinatol. 37, 414–419 (2017).
Article CAS PubMed Google Scholar
Altit, G., Bhombal, S., Feinstein, J., Hopper, R. K. & Tacy, T. A. Diminished right ventricular function at diagnosis of pulmonary hypertension is associated with mortality in bronchopulmonary dysplasia. Pulm. Circulation 9, 2045894019878598 (2019).
Altit G., Bhombal S., Hopper R. K., Tacy T. A., Feinstein J. Death or resolution: The “natural history” of pulmonary hypertension in bronchopulmonary dysplasia. J. Perinatol. 39, 415–425 (2019).
Abman, S. H. et al. Pediatric pulmonary hypertension: Guidelines from the american heart association and american thoracic society. Circulation 132, 2037–2099 (2015).
Altit, G. et al. Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature. Paediatr. Respir. Rev. 23, 16–26 (2017).
Abman, S. H. et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 75, 80–84 (1985).
Article CAS PubMed Google Scholar
Krishnan, U. et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J. Pediatr. 188, 24–34.e1 (2017).
Mourani, P. M. et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am. J. Respiratory Crit. Care Med. 191, 87–95 (2015).
Philip R., Lamba V., Talati A., Sathanandam S. Pulmonary hypertension with prolonged patency of the ductus arteriosus in preterm infants. Children (Basel) 7, 139 (2020).
Philip, R. et al. Hemodynamic and clinical consequences of early versus delayed closure of patent ductus arteriosus in extremely low birth weight infants. J. Perinatol. 41, 100–108 (2021).
Article CAS PubMed Google Scholar
Gentle, S. J., Travers, C. P., Clark, M., Carlo, W. A. & Ambalavanan, N. Patent ductus arteriosus and development of bronchopulmonary dysplasia with pulmonary hypertension. Am. J. Respir. Crit. Care Med. 207, 921–928 (2022).
Article PubMed Central Google Scholar
Benitz W. E. Patent ductus arteriosus in preterm infants. Pediatrics. 137, e20153730 (2016).
Benitz, W. E. & Bhombal, S. The use of non-steroidal anti-inflammatory drugs for patent ductus arteriosus closure in preterm infants. Semin. fetal neonatal Med. 22, 302–307 (2017).
Runte, K. E. et al. Variation of patent ductus arteriosus treatment in very low birth weight infants. Pediatrics. 148, e2021052874 (2021).
Altit, G. et al. Outcomes of extremely premature infants comparing patent ductus arteriosus management approaches. J. Pediatr. 235, 49–57.e2 (2021).
de Carvalho Nunes, G. et al. Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes. J. Perinatol. 42, 642–648 (2022).
Hundscheid, T. et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. N. Engl. J. Med. 388, 980–990 (2023).
(CNN) TCNN. Postnatal use of steroids for treatment of Chronic Lung Disease in GA<29 weeks. Annual Report by the Canadian Neonatal Network (CNN). 2019:145.
Fenton, T. R. & Kim, J. H. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 13, 59 (2013).
Article PubMed PubMed Central Google Scholar
Neu, J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr. Clin. North Am. 43, 409–432 (1996).
Article CAS PubMed PubMed Central Google Scholar
Bell, M. J. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 187, 1 (1978).
Article CAS PubMed PubMed Central Google Scholar
Papile, L.-A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J. pediatrics 92, 529–534 (1978).
Kluckow M., Jeffery M., Gill A., Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Archives of Disease in Childhood: Fetal and Neonatal Edition. 2014;99.
Network CN. Abstractor’s Manual. Canadian Neonatal Network. February 1, 2022; https://www.canadianneonatalnetwork.org/portal/Portals/0/CNN%20Manuals/CNN%20Manual_20220201.pdf:82.
Lai, W. W. et al. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 19, 1413–1430 (2006).
Abraham, S. & Weismann, C. G. Left ventricular end-systolic eccentricity index for assessment of pulmonary hypertension in infants. Echocardiography 33, 910–915 (2016).
Sehgal, A., Malikiwi, A., Paul, E., Tan, K. & Menahem, S. Right ventricular function in infants with bronchopulmonary dysplasia: Association with respiratory sequelae. Neonatology 109, 289–296 (2016).
Jone, P.-N., Hinzman, J., Wagner, B. D., Ivy, D. D. & Younoszai, A. Right ventricular to left ventricular diameter ratio at end-systole in evaluating outcomes in children with pulmonary hypertension. J. Am. Soc. Echocardiogr. 27, 172–178 (2014).
Higgins, R. D. et al. Bronchopulmonary dysplasia: Executive summary of a workshop. J. Pediatr. 197, 300–308 (2018).
Article PubMed PubMed Central Google Scholar
Stone, A. et al. Early histological changes of bronchopulmonary dysplasia and pulmonary hypertension may precede clinical diagnosis in preterm infants. Early Hum. Dev. 171, 105612 (2022).
Article CAS PubMed Google Scholar
Bhatt, A. J. et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am. J. Respiratory Crit. Care Med. 164, 1971–1980 (2001).
Schweintzger, S. et al. Normal echocardiographic reference values of the right ventricular to left ventricular endsystolic diameter ratio and the left ventricular endsystolic eccentricity index in healthy children and in children with pulmonary hypertension. Front Cardiovasc. Med. 9, 950765 (2022).
Article PubMed PubMed Central Google Scholar
Bambul Heck, P., Eicken, A., Kasnar-Samprec, J., Ewert, P. & Hager, A. Early pulmonary arterial hypertension immediately after closure of a ventricular or complete atrioventricular septal defect beyond 6months of age. Int J. Cardiol. 228, 313–318 (2017).
Article CAS PubMed Google Scholar
Kidd, L. et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 87, I38–I51 (1993).
Rosenzweig, E. B. & Barst, R. J. Congenital heart disease and pulmonary hypertension: Pharmacology and feasibility of late surgery. Prog. Cardiovasc Dis. 55, 128–133 (2012).
Suresh, K. & Shimoda, L. A. Lung circulation. Compr. Physiol. 6, 897–943 (2016).
Article PubMed PubMed Central Google Scholar
Rondelet, B. et al. Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 289, H2319–H2324 (2005).
Article CAS PubMed Google Scholar
Prihadi, E. A. et al. Morphologic types of tricuspid regurgitation. Charact. Prognostic Implic. JACC Cardiovasc Imaging 12, 491–499 (2019).
Vonk Noordegraaf, A., Westerhof, B. E. & Westerhof, N. The relationship between the right ventricle and its load in pulmonary hypertension. J. Am. Coll. Cardiol. 69, 236–243 (2017).
Lemyre, B., Dunn, M. & Thebaud, B. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants. Paediatr. Child Health 25, 322–326 (2020).
Article PubMed PubMed Central Google Scholar
Doyle, L. W., Halliday, H. L., Ehrenkranz, R. A., Davis, P. G. & Sinclair, J. C. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. J. Pediatr. 165, 1258–1260 (2014).
留言 (0)